The Association between Gallstone Disease & Metabolic Syndrome – A Prospective Observational Study
Authors/Creators
- 1. Assistant Professor, Department of Surgery, Pacific Medical College and Hospital (PMCH), Udaipur
- 2. Senior Professor, Department of Surgery and Principal& Dean, Pacific Medical College and Hospital (PMCH), Udaipur
Description
Background – Gall stone disease a common clinical condition ,mostly affecting the females. Its incidence is increasing in the recent times , owing to various risk factors.Previous literature have reported metabolic syndrome to be present in patients diagnosed with gall stone disease. Aims & Objectives- To assess the association between the presence of gallstone disease and metabolic Syndrome. Material & Methods- This prospective, observational study recruited patients (n=60, age range 20-65 yrs) having cholelithiasis who were admitted in the Department of Surgery , of our tertiary care Hospital from January 2023 to September 2023. Normal healthy persons (n=60, age range 20-65 yrs) with no evidence of cholelithiasis on ultrasonography were taken as controls.CBC, fasting blood sugar, serum lipid profile,ultrasonography was conducted. Metabolic syndrome was defined by adult treatment panel III (ATP III) criteria. Results – Both the groups were comparable with respect to age and gender & with no statistically significant difference. In the Case group, 24 (40%), while in control group 11(17% ) of the study participants fulfilled the criteria for metabolic syndrome which showed statistically significant difference (p<0.05). Waist circumference , diabetes mellitus , low serum high density lipoprotein were statistically significantly higher in Case group as compared to control group . Hypertension & serum triglycerides levels were also elevated in case group with no statistically significant difference. A positive association was found between waist circumference , DM & low serum high density lipoprotein & gall stone disease which was statistically significant(p<0.05). Conclusion – Metabolic syndrome was statistically significantly associated with gall stone disease & can be used to predict the risk . Increased waist circumference , diabetes & low serum high density lipoprotein are the noted findings in Gall stone disease & should be management to prevent any complications. Key words – Metabolic syndrome ,Gall stone disease, dyslipidemia, insulin resistance ,diabetes mellitus
Abstract (English)
Background – Gall stone disease a common clinical condition ,mostly affecting the females. Its incidence is increasing in the recent times , owing to various risk factors.Previous literature have reported metabolic syndrome to be present in patients diagnosed with gall stone disease. Aims & Objectives- To assess the association between the presence of gallstone disease and metabolic Syndrome. Material & Methods- This prospective, observational study recruited patients (n=60, age range 20-65 yrs) having cholelithiasis who were admitted in the Department of Surgery , of our tertiary care Hospital from January 2023 to September 2023. Normal healthy persons (n=60, age range 20-65 yrs) with no evidence of cholelithiasis on ultrasonography were taken as controls.CBC, fasting blood sugar, serum lipid profile,ultrasonography was conducted. Metabolic syndrome was defined by adult treatment panel III (ATP III) criteria. Results – Both the groups were comparable with respect to age and gender & with no statistically significant difference. In the Case group, 24 (40%), while in control group 11(17% ) of the study participants fulfilled the criteria for metabolic syndrome which showed statistically significant difference (p<0.05). Waist circumference , diabetes mellitus , low serum high density lipoprotein were statistically significantly higher in Case group as compared to control group . Hypertension & serum triglycerides levels were also elevated in case group with no statistically significant difference. A positive association was found between waist circumference , DM & low serum high density lipoprotein & gall stone disease which was statistically significant(p<0.05). Conclusion – Metabolic syndrome was statistically significantly associated with gall stone disease & can be used to predict the risk . Increased waist circumference , diabetes & low serum high density lipoprotein are the noted findings in Gall stone disease & should be management to prevent any complications. Key words – Metabolic syndrome ,Gall stone disease, dyslipidemia, insulin resistance ,diabetes mellitus
Files
IJPCR,Vol15,Issue11,Article135.pdf
Files
(358.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:8446a747b748c2e58e43f20415bdc9db
|
358.3 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-11-10
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue11,Article135.pdf
- Development Status
- Active
References
- 1. Shaffer EA. Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Current Gastroenterology Reports. 2005;7(2):132–140 2. Grundy SM: Cholesterol gallstones: a fellow traveler with metabolicsyndrome? Am J Clin Nutr 2004, 80:1–2. 3. Liu CM, Tung TH, Chou P, Chen VT, Hsu CT, Chien WS, Lin YT, Lu HF,Shih HC, Liu JH: Clinical correlation of gallstone disease in a Chinese population in Taiwan: experience at Cheng Hsin General Hospital.World J Gastroenterol 2006, 12:1281–1286. 4. Unisa S, Jagannath P, Dhir V, Khandelwal C, Sarangi L, Roy TK. Population-based study to estimate prevalence and determine risk factors of gallbladder diseases in the rural Gangetic basin of North India. HPB (Oxford). 2011 Feb; 13(2):117-25. doi: 10.1111/j.1477-2574.2010 .00255.x. Epub 2010 Dec 22. 5. Lin et al.: The association of metabolic syndrome and its factors with gallstone disease. BMC Family Practice 2014 15:138. 6. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109:433–438. 7. Nervi F, Miquel JF, Alvarez M. Gallbladder disease is associated with insulin resistance in a high risk Hispanic population. J Hepatol. 2006;45:299-305. 8. Ahmed JM, Mahmood R, Rana RS, Muhammad TP,Haider J, Siddiqui SS, et al. Metabolic syndrome: an indicator of complicated gall stone disease? Cureus.2018;10(11):e3659. 9. Adriano De Santis, Adolfo Francesco Attiti., et.al. Gall stone and Diabetes. A case control study in a free living population sample. Indian J. Med Sci, 2006; 60:72 81 10. Liew PL, Wang W, Lee YC, Huang MT, Lin YC, Lee WJ: Gallbladder disease among obese patients in Taiwan. Obes Surg 2007, 17:383– 390. 11. Peswani1 AR, Sequeira VJ, D'Silva M, Ghanwat S, Shah PP, Pint AC . Association between Gallstone Disease and Metabolic Syndrome.IJCMR 2019;6(10):1-5 12. Archard C, Thiers J. Le virlisme pilaire et son association a l'insuffisance glycolytique (diabe'te des femmes a barb). Bull Acad Natl Med. 1921;86:51-64. 13. Kumar N, Bansal S, Gupta S, Yadav BL, Verma P, Choudhary S. Association of metabolic syndrome with complicated gall stone disease: our experience. Int Surg J 2019;6:2543-7. 14. Mendez-Sanchez N, Chavez-Tapia NC, Motola-Kuba D,Sanchez-Lara K, Ponciano-Rodriguez G, Baptista H, Ramos MH, Uribe M. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol 2005; 11:1653- 7 15. Sawant A, Mankeshwar R, Shah S, Raghavan R, Dhongde G, Raje H et al. Prevalence Of Metabolic syndrome in urban area. Cholesterol 2011; 2011:1-7 16. Chen LY, Qiao QH, Zhang SC, Chen YH, Chao GQ, Fang LZ: Metabolic syndrome and gallstone disease. World J Gastroenterol 2012, 18:4215–4220. 17. Sanchez NM, Aponte JB, Tapia NC, Kuba DM,Lara KS, Radríguez GP, et al. Strong association between gallstones and cardiovascular disease. The Am J Gastroenterol. 2005; 100 (4):827-30. 18. Ata N, Kucukazman M, Yavuz B, Bulus H, Dal K, Ertugrul DT, Yalcin AA,Polat M, Varol N, Akin KO, Karabag A, Nazligul Y: The metabolic syndrome is associated with complicated gallstone disease. Can J Gastroenterol 2011, 25:274–276. 19. Ching Lin I, Yang YW, Wu MF, Yeh YH, Liou JC,Lin YL et al. The association of metabolicsyndrome and its factors with gallstone disease.BMC Family Practice. 2014;15:138. 20. Nakeeb A, Comuzzie AG, Al-Azzawi H,Sonnenberg GE, Kissebah AH, Pitt HA. Insulin resistance causes human gallbladder dysmotility. J Gastrointest Surg. 2006;10:940-8. 21. Nagraj SK et al Risk Factors and the Biochemical Evaluation of Biliary Calculi in Rural Kolar; Journal of Clinical and Diagnostic Research. 2012;6:364-368 22. Devaki RN; Correlation of serum lipids and glucose tolerance test in Cholelithiasis, International Journal of Pharma and Bio Sciences 2011;2:12-18 23. Ruotolo G, Howard BV. Dyslipidemia of the metabolic syndrome. Curr Cardiol Rep. 2002 Nov;4(6):494-500. doi: 10.1007/s11886-002- 0113-6. PMID: 12379172.